Pedro Herranz-Pinto

12PUBLICATIONS
90CO-AUTHORS
Epidemiological methodsPeripheral nervous systemClinical pharmacology and therapeuticsPharmacogenomicsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 21, 2026
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.

|Mar 17, 2026
Impact of Chronic Nodular Prurigo on Quality of Life: A Systematic Review of the Literature.

Pedro Herranz Pinto, Bibiana Pérez García, Victoria Bonne Moreno

|Aug 22, 2024
Efficacy and Safety of Topical Roflumilast for the Treatment of Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Rafaela de Moraes-Souza, Regina Chahine Chater, Izabela Pera Calvi

|Jul 04, 2023
Real-world Performance of a New Strategy for Off-Label Use of Guselkumab in Moderate to Severe Psoriasis: Super-Responder Patients as the Epitome of Efficacy and Optimisation.

Pedro Herranz-Pinto, Maria Luisa Alonso-Pacheco, Rosa Feltes-Ochoa

|Oct 29, 2021
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis.

Gil Yosipovitch, Marjolein de Bruin-Weller, April Armstrong

|Jun 02, 2021
Psoriasis and Liver Damage in HIV-Infected Patients.

Carmen Busca Arenzana, Lucía Quintana Castanedo, Clara Chiloeches Fernández

Pageof 2

Frequent Collaborators

2 joint publications

Rafaela de Moraes-Souza

2 joint publications

Diamant Thaçi

2 joint publications

Izabela Pera Calvi

2 joint publications

Leon Kircik